Rockefeller Capital Management
ANGO icon

Rockefeller Capital Management’s AngioDynamics ANGO Stock Holding History

Rockefeller Capital Management’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.07K Sell
313
-350
-53% -$3.98K ﹤0.01% 4290
2026
Q1 		$7.54K Buy
663
+530
+398% +$5.74K ﹤0.01% 4110
2025
Q4 		$1.71K Buy
+133
New +$1.64K ﹤0.01% 4358
2023
Q1 		– Sell
-17
Closed – – 2062
2022
Q4 		$0 Hold
17
– – ﹤0.01% 3832
2022
Q3 		$0 Sell
17
-38
-69% -$834 ﹤0.01% 3862
2022
Q2 		$1K Buy
+55
New +$1.13K ﹤0.01% 3897

Other funds holding ANGO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $5.02B AUM 66.06% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
BH
Broadfin Holdings Melville, New York $23.7M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WCM
Weber Capital Management San Francisco, California $118M AUM
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Rockefeller Capital Management's ANGO Position: Q2 2026 in Review

Rockefeller Capital Management reduced its AngioDynamics (ANGO) stake by 53% in Q2 2026, selling an estimated $3.98K and leaving 313 shares worth $4.07K. The position accounts for ﹤0.01% of the portfolio, ranked #4290.

Rockefeller Capital Management first reported a position in ANGO in Q2 2022 and has held it in 6 quarters since. The position peaked at $7.54K in Q1 2026. 161 funds tracked by Wall St. Rank hold ANGO as of Q2 2026.

  • Rockefeller Capital Management held 313 shares of AngioDynamics worth $4.07K as of Q2 2026.
  • Rockefeller Capital Management sold 350 AngioDynamics shares in Q2 2026, an estimated $3.98K.
  • AngioDynamics made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q2 2026, its #4290 holding.
  • Rockefeller Capital Management first reported a position in AngioDynamics in Q2 2022 and has held it in 6 quarters since.
  • Rockefeller Capital Management's AngioDynamics position peaked at $7.54K in Q1 2026.
  • 161 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2026.

Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.